Form 4 for AVXL ANAVEX LIFE SCIENCES CORP.
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001731122-22-001013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-27 | 2022-05-25 | AVXL | Skarpelos Athanasios | Dir | M - OptEx | $0.92 | +50.0K | 1.36M | +4% | +$46.0K |
| D | 2022-05-27 | 2022-05-25 | AVXL | Skarpelos Athanasios | Dir | S - Sale+OE | $9.06 | -50.0K | 1.31M | -4% | -$453.0K |
| D | 2022-05-27 | 2022-05-25 | AVXL | Skarpelos Athanasios | Dir | M - OptEx | $0.00 | +50.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-25 | M | A | 50,000 | $0.92 | 1,356,458 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-25 | S | D | 50,000 | $9.06 | 1,306,458 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-05-25 | M | A | 50,000 | $0.00 | 0 | D | $0.92 · — to 2025-04-02 | 50,000 Common Stock | (F1) The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015. |